Lihua Zhang, Ningyi Jiang. The advantage and risk of 131I treatment in hyperthyroidism combined with liver injury or blood cell reduction[J]. Int J Radiat Med Nucl Med, 2015, 39(6): 483-486,492. DOI: 10.3760/cma.j.issn.1673-4114.2015.06.010
Citation: Lihua Zhang, Ningyi Jiang. The advantage and risk of 131I treatment in hyperthyroidism combined with liver injury or blood cell reduction[J]. Int J Radiat Med Nucl Med, 2015, 39(6): 483-486,492. DOI: 10.3760/cma.j.issn.1673-4114.2015.06.010

The advantage and risk of 131I treatment in hyperthyroidism combined with liver injury or blood cell reduction

  • At present, anti-thyroid drugs, radioactive iodine(131I) and surgical therapy were considered as the three major methods for hyperthyroidism therapy. With the acceptance of the safety of 131I therapy in hyperthyroidism, more and more patients become to choose it as their therapeutic method, especially the patients with liver injury or blood cell reduction complications. This paper summaries the advantages and risks of 131I therapy in this two special hyperthyroidism patients groups according to the recent paper and clinical practice.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return